Cyclin D1 expression in primary thyroid carcinomas

Neuroendocrinology Letters

Volumn 26, Issue 6, 2005, Pages 815-818

  Sporny, Stanislaw ^a   Slowinska Klencka, Dorota ^a   Ratynska, Marzena ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cyclin D1; Immunohistochemistry; Thyroid carcinomas

Indexed keywords

CYCLIN D1; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; MEDULLARY CARCINOMA; PAPILLARY CARCINOMA; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RISK FACTOR; STATISTICAL ANALYSIS; THYROID CARCINOMA; THYROID CELL;

EID: 33644999319     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Musial J, Sporny S, Ferenc T, Lewinski A. Cyklina D1 - nowy marker zlosliwosci nowotworow. [(Cyclin D1 - a new marker of neoplasm malignancy.) (in Polish with English abstract.)] Endocrinol Pol 2002; 53:379-86.
2. Wang S, Wuu J, Savas L, Patwardhan N, Khan A. The role of cell cycle regulatory proteins, cyclin D1, cyclin E and p27 in thyroid carcinogenesis. Hum Pathol 1998; 29:1304-9.
3. Muro-Cacho CA, Holt T, Klotch D, Mora L, Livingston S, Futran N. Cyclin D1 expression as a prognostic parameter in papillary carcinoma of the thyroid. Otolaryngol Head Neck Surg 1999; 120:200-7.
4. Khoo ML, Beasley NJ, Ezzat S, Freeman JL, Asa SL. Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma. J Clin Endocrinol Metab 2002; 87:1814-8.
5. Wang S, Lloyd RV, Hutzler MJ, Safran MS, Pathwardhan NA, Khan A. The role of cell cycle regulatory protein, cyclin D1, in progression of thyroid cancer. Mod Pathol 2000; 13:882-7.
6. Goto A, Sakamoto A, Machinami R. An immunohistochemical analysis of cyclin D1, p53 and p21 protein in tumors originating from the follicular epithelium of the thyroid gland. Pathol Res Pract 2001; 197:217-22.
7. Kim JY, Cho H, Rhee BD, Kim HY. Expression of CD44 and cyclin D1 in fine needle aspiration cytology of papillary thyroid carcinoma. Acta Cytol 2002; 46:679-83.
8. Bieche I, Franc B, Vidaud D, Vidaud M, Lidereau R. Analyses of MYC, ERBB2 and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction. Thyroid 2001; 11:147-52.
9. Grzelakowska-Sztabert B. Cykliny fazy G1 cyklu komorkowego, ich funkcje i udzial w nowotworzeniu.[(Cyclin D1, their cellular functions and participation in oncogenesis)(In Polish)] Postepy Biochemii 1996; 42:99-107.
10. Basolo F, Caligo MA, Pinchera A, Fedeli F, Baldanzi A, Miccoli P et al. Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product and Ki67 labeling index. Thyroid 2000; 10:741-6.
11. Lazzereschi D, Sambuco L, Carnovale Scalzo C, Ranieri A, Minicione G, Nardi F et al. Cyclin D1 and cyclin E expression in malignany thyroid cells and in human thyroid carcinomas. Int J Cancer 1998; 76:806-11.
12. Khoo ML, Ezzat S, Freeman JL, Asa SL. Cyclin D1 protein expression predict metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification. J Clin Endocrinol Metab 2002; 87:1810-3.
13. Saiz AD, Olvera M, Rezk S, Florentine BA, McCourty A, Brynes RK. Immunohistochemical expression of cyclin D1, E2F-I and Ki67 in benign and malignant thyroid lesions. J Pathol 2002; 198:157-62.